TWiV 1265: mRNA vaccines make cancer treatment great again
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
TWiV explains studies showing that SARS-CoV-2 mRNA vaccines improve life span of cancer patients on checkpoint immunotherapy, and broad immunity conferred by a vaccine central in A(H5) influenza antigenic space.
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy SpindlerSubscribe (free): Apple Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Support science education at MicrobeTV
- Immune 100 live at the Incubator
- SARS-CoV-2 mRNA vaccines sensitize tumors to checkpoint immunotherapy (Nature)
- People with some cancers live longer after mRNA vaccines (Nature)
- Immune checkpoint inhibitors (NCI)
- Broad immunity from influenza H5 vaccine (Nature)
- Derek Smith on antigenic cartography (TWiV 99 at 2:53)
- Letters read on TWiV 1265
- Timestamps by Jolene Ramsey. Thanks!
Kathy – Permethrin-treated baby wraps for malaria prevention and Phil Sharp and the Biotech Revolution
Rich – Lydia Fairchild; Tetragametic Chimerism (NEJM)
Alan – Warning Signs
Vincent – radio.garden thanks to Kim!
Jamie – SkyCards by Flightradar24
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv
Content in this podcast should not be construed as medical advice.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.